Replix锐璞美股2021-03-03 20:20
$Passage Bio(PASG)$ $PASG$ Reports Fourth Quarter and Full-Year 2020 Financial Results and Recent Business Highlights
- On track to initiate three Phase 1/2 clinical programs in the first half of 2021: PBGM01 for GM1 gangliosidosis (GM1), PBFT02 for frontotemporal dementi...查看全文
医药魔方2021-01-21 21:41
2020年1月,基因疗法开发商Generation Bio完成了1.1亿美元的C轮融资用以推进其A型血友病和苯丙酮尿症治疗药物的开发;5个月后,Generation又进行了首次公开募股(IPO),募资2.3亿美元。这无疑是一个迹象,表明投资者对下一代治疗罕见疾病的基因疗法非常感兴趣。
去年一年,尽管面临着各种挑战...查看全文
Replix锐璞美股2020-08-29 13:01
$Iovance(IOVA)$ 看看未来会发生什么。$Passage Bio(PASG)$ $CRISPR Therapeutics(CRSP)$查看全文
chuminhua2020-05-08 16:18
5/7,Passage Bio$Passage Bio(PASG)$ 与美国宾夕法尼亚大学去年达成合作,获得5款基因疗法,以及7个基因疗法的选择权。现在两家公司扩展了合作,增加了5个新项目,总计达到17个。合作期限也从2022年延长至2025年。作为回报,每年将向该大学提供500万美元。查看全文
chuminhua2020-02-28 23:21
2/27,Passage Bio$Passage Bio(PASG)$ 在Nasdaq IPO,发行价为18美元,共募集了2.16亿美元,比最初计划多72%。该公司聚焦基因疗法,与Frazier和OrbiMed合作,致力于开发罕见CNS单基因疾病的疗法。交易代码为$ PASG。查看全文
$Passage Bio(PASG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-023477 Size: 5 KB 网页链接
$Passage Bio(PASG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-023478 Size: 5 KB 网页链接
$Passage Bio(PASG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-023479 Size: 5 KB 网页链接
$Passage Bio(PASG)$ PRE 14A Other preliminary proxy statements Accession Number: 0001104659-23-040826 Act: 34 Size: 900 KB 网页链接
$Passage Bio(PASG)$ 8-K Current report, item 7.01 Accession Number: 0001104659-23-031221 Act: 34 Size: 202 KB 网页链接
$Passage Bio(PASG)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001104659-23-028902 Act: 33 Size: 397 KB 网页链接
$Passage Bio(PASG)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001558370-23-002833 Act: 34 Size: 9 MB 网页链接
$Passage Bio(PASG)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001558370-23-002831 Act: 34 Size: 7 MB 网页链接
$Passage Bio(PASG)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001558370-23-001964 Act: 34 Size: 3 MB 网页链接
$Passage Bio(PASG)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902664-23-001802 Act: 34 Size: 66 KB 网页链接